This document is a guideline for anesthesia in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.
This document is a clinical guide for specialists addressing the increased anesthetic risks associated with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (DMB). It highlights risks related to cardiovascular and respiratory alterations, as well as the potential for dangerous pathological processes triggered by certain anesthetic drugs. The guide is based on recommendations from a Consensus Conference held in Turin in October 2011, supported by SIAARTI and AIM. This manual is written in Spanish.
Patients requiring training include those with forced vital capacity less than 50% of normal, daytime hypercapnia with PaCO2 greater than 45 mmHg, or significant nocturnal desaturations where SpO2 drops below 90% for more than 10% of sleep.
The peak cough flow must be at least 270 liters per minute for the patient to be considered capable of performing the test reliably.
The use of halogenated inhalational anesthetics and succinylcholine must be absolutely avoided in these patients.